Eye bleeding study seeks best fix for macular degeneration patients
NCT ID NCT02557451
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 91 people with a type of bleeding in the eye caused by age-related macular degeneration (AMD). It compared two treatments: surgery followed by anti-VEGF injections, or a gas injection followed by anti-VEGF injections. The goal was to see which approach helps patients recover vision and quality of life better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBRETINAL HAEMATOMA LINKED TO AMD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Hôpital Lariboisière
Paris, 75010, France
-
CH de COLMAR
Colmar, 68000, France
-
CH de MULHOUSE
Mulhouse, 68100, France
-
CH de NEVERS
Nevers, 58000, France
-
CHI de CRETEIL
Créteil, 94000, France
-
CHR de METZ-THIONVILLE
Metz, 57085, France
-
CHU de BESANCON
Besançon, 25030, France
-
CHU de Bordeaux
Bordeaux, 33000, France
-
CHU de DIJON
Dijon, 21079, France
-
CHU de GRENOBLE
Grenoble, 38043, France
-
CHU de NANCY
Vandœuvre-lès-Nancy, 54500, France
-
CHU de REIMS
Reims, 51092, France
-
CHU de TOULOUSE - Hôpital Purpan
Toulouse, 31300, France
-
Clinique Mathilde
Rouen, 76100, France
-
Fondation Ophtalmologique A. de Rothschild
Paris, 75019, France
-
HCL - Hôpital de la Croix-Rousse
Lyon, 69004, France
-
NHC de STRASBOURG
Strasbourg, 67091, France